Trial
NCT00284531
Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
Roche Pharma AG
Condition
Cardiac Transplantation
Intervention
Daclizumab
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-16